Tofacitnib for the Treatment of Alopecia Areata and Variants
Phase of Trial: Phase II
Latest Information Update: 07 Apr 2017
Price : $35 *
At a glance
- Drugs Tofacitinib (Primary)
- Indications Alopecia areata
- Focus Therapeutic Use
- 08 Aug 2016 Status changed from active, no longer recruiting to completed.
- 15 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 30 Jul 2014 New trial record